Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.01310
Full Text
Open PDFAbstract
Available in full text
Date
June 11, 2018
Authors
Publisher
Frontiers Media SA